EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer

Caiqi Huang, Huimin Liu, Jia Ming

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189603

DOI: 10.1016/j.bbcan.2026.189603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Caiqi Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 264 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer has emerged as the most prevalent malignant tumor among women worldwide. Its intricate and highly heterogeneous pathogenesis presents substantial challenges for effective treatment. In recent years, the increasing prominence of tumor immunotherapy has highlighted the pivotal role of protein glycosylation, particularly its regulation of glycan structural alterations in the initiation, progression, and immune evasion mechanisms of breast cancer. Evidence suggests that glycan modifications-such as N-glycosylation, O-glycosylation, fucosylation, and sialylation-not only significantly influence tumor cell biology but also directly modulate the function and stability of key immune checkpoint molecules, including PD-1/PD-L1, CD24, and members of the B7 family. Aberrant glycosylation in breast cancer cells fosters the establishment of an immunosuppressive microenvironment, a critical factor that limits the efficacy of immunotherapy. Consequently, interventions targeting glycosylation modifications present promising strategies to enhance the therapeutic response to immunotherapy in breast cancer patients. Thus, our comprehensive exploration of the underlying mechanisms of glycosylation modifications in breast cancer immunotherapy provides a robust theoretical foundation and identifies novel intervention targets to overcome the therapeutic challenges faced in breast cancer and other immunologically "cold" tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansGlycosylationFemaleImmunotherapyAnimalsTumor MicroenvironmentPolysaccharides

Stichwörter der Autor:innen

Breast cancerImmunotherapyProtein glycosylation

Substanzen

Polysaccharides

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University, China.
  • School of Traditional Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, China.
  • Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University, China. Electronic address: mingjia@cqmu.edu.cn.

Zitieren

APA

Huang, C., Liu, H., & Ming, J. (2026). The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189603. https://doi.org/10.1016/j.bbcan.2026.189603

Vancouver

Huang C, Liu H, Ming J. The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189603. doi:10.1016/j.bbcan.2026.189603

BibTeX
@article{Huang2026,
  author = {Huang, Caiqi and Liu, Huimin and Ming, Jia},
  title = {The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {4},
  pages = {189603},
  doi = {10.1016/j.bbcan.2026.189603}
}
Kostenlos starten →